CN103585417A

CN103585417A - Agentiafor treating idiopathic trigeminal neuralgia

Info

Publication number: CN103585417A
Application number: CN201310586682.4A
Authority: CN
Inventors: 张霞
Original assignee: Individual
Current assignee: Individual
Priority date: 2013-11-20
Filing date: 2013-11-20
Publication date: 2014-02-19
Anticipated expiration: 2033-11-20
Also published as: CN103585417B

Abstract

The invention relates to an agentia for treating idiopathic trigeminal neuralgia. The agentia for treating idiopathic trigeminal neuralgia comprises the following bulk drugs in parts by weight: 10 parts of microsoriumbuergerianum, 15 parts of tongking pepper, 15 parts of paniculategoldraintree flower, 20 parts of heliotropiumindicum, 10 parts of korsakow'smonochoria, 10 parts of woodfordiafruticosa, 5 parts of RganbaceaeRhamnellarubrinervis, 15 parts of willow herb, 15 parts of herbaveronicaedilatatae, 10 parts of Indigoferatinctoria, 15 parts of yellowflowertoadlily herb and 10 parts of twinleaf zornia herb. The agentia for treating idiopathic trigeminal neuralgia, provided by the invention, uses natural medicines, takes effect quickly, has a good curative effect, and is quite suitable for treating the idiopathic trigeminal neuralgia.

Description

A kind of medicament for the treatment of primary trigeminal neuralgia

Technical field

The present invention relates to nursing in neurology field, specifically, relate to a kind of medicament for the treatment of primary trigeminal neuralgia.

Background technology

Primary trigeminal neuralgia refers to that recurrent paroxysmal transience has an intense pain in facial nervi trigeminus distributed areas, conventionally with the muscle twitches of homonymy face, but numbness lacks as, the Nerve conduction Novel presentation such as the dyskinesia.Because its pain cut-like pain, bore spine, fire burn, electric shock, some patient loses life confidence because of hurt like hell.

At present, for the needs for the treatment of the medicine of primary trigeminal neuralgia, constantly strengthen.

Summary of the invention

The object of this invention is to provide a kind of medicament for the treatment of primary trigeminal neuralgia.

In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of primary trigeminal neuralgia, it is to be made by weight by following bulk drugs: 5 parts of 6 parts, flag, 3 parts of Herba Piperris Tonkinensiss, 6 parts of Flos koelreuteriae paniculatae, 8 parts of Herba Heliotroph, 5 parts of Herba Monochoriae Korsakowii, 5 parts, 2 parts, ten liang leaves of Flos Woodfordiae Fruticosae, 6 parts of Herba Epilobii Angustifoii, 7 parts of HERBA VERONICAE DILATATAEs, 5 parts of Herba indigoferae bungeanae, 3 parts of Herba Tricyrtis Pilosaes and Herba Zornia Diphyllae.

Preferably, described medicament is tablet, capsule, decoction, powder or granule.

accompanying drawing explanation

According to < < Chinese medicine voluminous dictionary > > second edition, the Chinese crude drug that used is in the present invention described as follows:

Fig. 1 is the explanation of a flag;

Fig. 2 is the explanation of Herba Piperris Tonkinensis;

Fig. 3 is the explanation of Flos koelreuteriae paniculatae;

Fig. 4 is the explanation of Herba Heliotroph;

Fig. 5 is the explanation of Herba Monochoriae Korsakowii;

Fig. 6 is the explanation of Flos Woodfordiae Fruticosae;

Fig. 7 is the explanation of ten liang of leaves;

Fig. 8 is the explanation of Herba Epilobii Angustifoii;

Fig. 9 is the explanation of HERBA VERONICAE DILATATAE;

Figure 10 is the explanation of Herba indigoferae bungeanae;

Figure 11 is the explanation of Herba Tricyrtis Pilosae;

Figure 12 is the explanation of Herba Zornia Diphyllae.

The medicament for the treatment of primary trigeminal neuralgia of the present invention is used natural drug, and its instant effect, good effect, be very suitable for treating primary trigeminal neuralgia.

The specific embodiment

Below the invention will be further described for the description by the specific embodiment, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.

The preparation of embodiment 1 powder of the present invention

Get 50 grams of 60 grams, a flag, 30 grams of Herba Piperris Tonkinensiss, 60 grams of Flos koelreuteriae paniculatae, 80 grams of Herba Heliotroph, 50 grams of Herba Monochoriae Korsakowii, 50 grams, 20 grams, ten liang leaves of Flos Woodfordiae Fruticosae, 60 grams of Herba Epilobii Angustifoii, 70 grams of HERBA VERONICAE DILATATAEs, 50 grams of Herba indigoferae bungeanae, 30 grams of Herba Tricyrtis Pilosaes and Herba Zornia Diphyllae, pulverize, cross 100 mesh sieves, then add 200 grams of 100 grams of lactose and Icing Sugar, mix, pack in 200 bags and get final product.

Experimental example

Physical data

97 routine patients, male's 44 examples wherein, women's 53 examples, age 19-29 year 20 examples, account for 20.62%, and 30-67 year 77 examples, account for 79.38%, and course of disease 5d-11 is in the majority with person in 3 months-5 years.

Diagnostic criteria

1. facial nervi trigeminus distributed areas occur that paroxysmal lightning sample, the sample that lancinates have an intense pain, last the several seconds to tens of seconds, outbreak time and again, character is identical, outbreak is intermittently asymptomatic, and 2. paroxysmal pain is positioned at the one or more of side nervi trigeminus distributed areas, the not criminal's of crossing the border larynx, occipitalia or offside, 3. patient Chang Yin mouth, tongue motion or external irritant cause paroxysmal pain, and one " trigger point " often deposited in buccal portion, lip, oral cavity.Patient is for fear of causing that pain usually dare not wash one's face, brushes teeth, lack diet, and 4. neurologic check is without positive sign, and the sensation of nervi trigeminus distributed areas and masticatory muscles are all without abnormal.

With the powder making in embodiment 1, treat, wherein one day 2 times, each one bag, treating 15 days is a course for the treatment of.

Curative effect determinate standard

1. recovery from illness: pain disappears completely, diet and sleep are all normal.2. effective: pain obviously alleviates, diet and sleep normal.3. effective: pain relief, attack times is treated front obvious minimizing, and diet and sleep all have to a certain degree improvement.4. invalid: after 1 course for the treatment of of above-mentioned treatment, pain degree and attack times all, without improving, even increase the weight of.

Therapeutic outcome

Above-mentioned case is after treatment, and 97 routine patients' pain disappears completely, and diet and sleep are all normal, therefore all meets the curative effect determinate standard of recovery from illness., in therapeutic process, all there is not serious adverse reaction in above case.

Claims

1. a medicament for the treatment of primary trigeminal neuralgia, it is characterized in that, it is made by weight by following bulk drugs: 5 parts of 6 parts, flag, 3 parts of Herba Piperris Tonkinensiss, 6 parts of Flos koelreuteriae paniculatae, 8 parts of Herba Heliotroph, 5 parts of Herba Monochoriae Korsakowii, 5 parts, 2 parts, ten liang leaves of Flos Woodfordiae Fruticosae, 6 parts of Herba Epilobii Angustifoii, 7 parts of HERBA VERONICAE DILATATAEs, 5 parts of Herba indigoferae bungeanae, 3 parts of Herba Tricyrtis Pilosaes and Herba Zornia Diphyllae.

2. the medicament for the treatment of primary trigeminal neuralgia according to claim 1, is characterized in that, described medicament can be tablet, capsule, decoction, powder or granule.